Literature DB >> 4978744

Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement.

R J Pickering, M R Wolfson, R A Good, H Gewurz.   

Abstract

The studies presented here indicate that activation of the complement (C') system by a foreign protein will cause membrane injury and passive lysis of unsensitized erythrocytes present at the time of the reaction. These observations suggest that in addition to the classical antibody-C'-induced cytolysis, there are alternative pathways or mechanisms for activation and participation of the terminal C' components in the production of cell membrane injury. We have shown that a substance derived from cobra venom and eluted from a single protein band on polyacrylamide can promote lysis of unsensitized autologous or heterologous erythrocytes in the presence of fresh guinea pig serum and that this lysis-inducing activity and C'-inhibiting activity appear to reside in the same fractions. The lytic activity is prevented by several agents known to impair classical C'3 activity, but is unaffected by certain procedures which interfere with the function of C' components C'1 and C'2, a suggestion that this reaction involves chiefly C'3-C'9. Further, the cobra venom (CV) factor depletes C' activity in cobra serum, and the CV factor (with its 5S serum cofactor) converts purified C'3 to its inactive form,(1) indicating that the reaction of this complex with the complement system occurs without participation of antibody. Therefore, since the lysis-inducing and C'-inhibiting activity of the CV factor appear to result from similar interactions with the complement system, these observations suggest that cell membrane damage and cell lysis can be accomplished through activation of the complement system by a mechanism involving little or no participation of classical antibody or C' components C'1, 4, or 2.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4978744      PMCID: PMC277829          DOI: 10.1073/pnas.62.2.521

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  The inhibition of immune haemolysis by salicylaldoxime.

Authors:  S E MILLS; L LEVINE
Journal:  Immunology       Date:  1959-10       Impact factor: 7.397

2.  On the nature of immunological tolerance.

Authors:  M M Azar; E J Yunis; P J Pickering; R A Good
Journal:  Lancet       Date:  1968-06-15       Impact factor: 79.321

Review 3.  Chemistry and reaction mechanisms of complement.

Authors:  H J Müller-Eberhard
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

4.  Effect of cobra venom-induced inhibition of complement activity on allograft and xenograft rejection reactions.

Authors:  H Gewurz; D S Clark; M D Cooper; R L Varco; R A Good
Journal:  Transplantation       Date:  1967-09-05       Impact factor: 4.939

5.  Complement-mediated hemolysis in agar gel.

Authors:  F Milgrom; U Loza
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

6.  A new concept of immunosuppression in hypersensitivity reactions and in transplantation immunity.

Authors:  R A Nelson
Journal:  Surv Ophthalmol       Date:  1966-08       Impact factor: 6.048

7.  Anaphylatoxin in its relation to the complement system.

Authors:  J Jensen
Journal:  Science       Date:  1967-03-03       Impact factor: 47.728

8.  Interactions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocytes.

Authors:  R Snyderman; H Gewurz; S E Mergenhagen
Journal:  J Exp Med       Date:  1968-08-01       Impact factor: 14.307

9.  Interactions of the complement system with the surface and endotoxic lipopolysaccharide of Veillonella alcalescens.

Authors:  H A Bladen; H Gewurz; S E Mergenhagen
Journal:  J Exp Med       Date:  1967-05-01       Impact factor: 14.307

10.  Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components.

Authors:  H Gewurz; H S Shin; S E Mergenhagen
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  27 in total

Review 1.  Mechanisms of oxidant-induced changes in erythrocytes.

Authors:  J R Hatherill; G O Till; P A Ward
Journal:  Agents Actions       Date:  1991-03

2.  Calcium-independent haemolysis via the lectin pathway of complement activation in the guinea-pig and other species*.

Authors:  Y Zhang; C Suankratay; X Zhang; D R Jones; T F Lint; H Gewurz
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

3.  Purification of cobra venom factor from phospholipase A contaminant.

Authors:  P J Lachmann; L Halbwachs; A Gewurz; H Gewurz
Journal:  Immunology       Date:  1976-12       Impact factor: 7.397

4.  Ischemia-reperfusion in humans. Appearance of xanthine oxidase activity.

Authors:  H P Friedl; D J Smith; G O Till; P D Thomson; D S Louis; P A Ward
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

5.  Thermal injury, intravascular hemolysis, and toxic oxygen products.

Authors:  J R Hatherill; G O Till; L H Bruner; P A Ward
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

6.  Interaction of toxic venoms with the complement system.

Authors:  V Birdsey; J Lindorfer; H Gewurz
Journal:  Immunology       Date:  1971-08       Impact factor: 7.397

7.  Studies on the inhibition of C56-initiated lysis (reactive lysis). V. The roleof C567-INH in the regulation of complement-dependent haemolysis initiated by cobravenom factor.

Authors:  B McLeod; T F Lint; P Baker; C Behrends; H Gewurz
Journal:  Immunology       Date:  1975-04       Impact factor: 7.397

8.  Continuing C3 breakdown after bilateral nephrectomy in patients with membrano-proliferative glomerulonephritis.

Authors:  E H Vallota; J Forristal; R E Spitzer; N C Davis; C D West
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

9.  Specific inactivation of the fourth complement component. I. In vivo studies.

Authors:  J A Jensen; M C Garces; E Iglesias
Journal:  Infect Immun       Date:  1971-07       Impact factor: 3.441

10.  Role of oxygen radicals in tourniquet-related ischemia-reperfusion injury of human patients.

Authors:  H P Friedl; G O Till; O Trentz; P A Ward
Journal:  Klin Wochenschr       Date:  1991-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.